Ralson Remedies Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 04-10-2024
- Paid Up Capital ₹ 3.56 M
as on 04-10-2024
- Company Age 34 Year, 22 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 3.21 M
as on 04-10-2024
- Revenue 9.29%
(FY 2022)
- Profit 41.54%
(FY 2022)
- Ebitda 2.96%
(FY 2022)
- Net Worth 7.55%
(FY 2022)
- Total Assets -1.87%
(FY 2022)
About Ralson Remedies
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 3.56 M.
The company currently has active open charges totaling ₹3.21 M.
Krishna Rani, Nidhi Wahi, Priyanka Arora, and One other member serve as directors at the Company.
- CIN/LLPIN
U74899DL1990PTC063191
- Company No.
063191
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Nov 1990
- Date of AGM
20 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- LocationNa, Delhi
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Ralson Remedies?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Krishna Rani  | Director | 28-Jan-2008 | Current |
| Nidhi Wahi | Director | 29-Nov-1990 | Current |
| Priyanka Arora | Director | 25-Jan-1992 | Current |
| Hulas Wahi | Director | 26-Aug-2021 | Current |
Financial Performance and Corporate Structure Insights of Ralson Remedies.
Ralson Remedies Pvt Ltd, for the financial year ended 2022, experienced modest growth in revenue, with a 9.29% increase. The company also saw a substantial improvement in profitability, with a 41.54% increase in profit. The company's net worth moved up by a moderate rise of 7.55%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ralson Remedies?
In 2019, Ralson Remedies had a promoter holding of 63.48% and a public holding of 36.52%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Ralson Communication Technologies Private LimitedActive 35 years 8 monthsKrishna Rani is a mutual person
_LIMITED.webp)
Ralco Finance And Investments Private LimitedActive 32 years 10 monthsKrishna Rani is a mutual person
_LIMITED.webp)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 20 May 2022 | ₹1.51 M | Open |
Others Creation Date: 05 Jul 2016 | ₹1.70 M | Open |
How Many Employees Work at Ralson Remedies?
Unlock and access historical data on people associated with Ralson Remedies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ralson Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ralson Remedies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
